Celldex Therapeutics Inc (CLDX)
Working Capital Ratio
84.82%
Quarterly · Period ending:
CLDX Working Capital Ratio
Latest reported84.82%period ending
Latest reported84.82%period ending
CLDX Quarterly Working Capital Ratio (71.88% → 84.82%)
Quarterly working capital ratio
High-resolution chart · PNG
CLDX working capital ratio history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Working Capital Ratio |
|---|---|
| 84.8222% | |
| 79.7549% | |
| 82.9652% | |
| 86.0334% | |
| 88.8843% | |
| 89.4882% | |
| 89.3124% | |
| 90.7153% | |
| 92.7543% | |
| 93.1157% | |
| 86.0277% | |
| 77.8206% | |
| 83.2492% | |
| 84.5491% | |
| 84.7897% | |
| 86.2106% | |
| 83.8865% | |
| 88.7035% | |
| 88.6782% | |
| 89.6085% | |
| 74.8557% | |
| 75.1019% | |
| 77.8657% | |
| 74.5689% | |
| 75.8035% | |
| 39.9861% | |
| 44.7846% | |
| 47.9479% | |
| 51.219% | |
| 52.0826% | |
| 55.5019% | |
| 55.9271% | |
| 56.2281% | |
| 55.89% | |
| 37.0758% | |
| 38.3203% | |
| 37.9298% | |
| 40.6721% | |
| 41.8267% | |
| 75.8429% | |
| 76.9817% | |
| 78.047% | |
| 78.4089% | |
| 80.9969% | |
| 81.6378% | |
| 84.1258% | |
| 72.7757% | |
| 76.6426% | |
| 78.7639% | |
| 80.7383% | |
| 82.0637% | |
| 68.0561% | |
| 73.345% | |
| 74.0414% | |
| 53.7107% | |
| 53.138% | |
| 55.5306% | |
| 59.7411% | |
| 41.2127% | |
| 49.4283% | |
| 53.074% | |
| 40.3749% | |
| 38.8738% | |
| 32.1253% | |
| 36.6346% | |
| 40.3632% | |
| 49.5633% | |
| 28.9032% | |
| 37.9567% | |
| 43.7707% | |
| 47.2465% | |
| 46.898% | |
| 56.6% | |
| 27.4435% | |
| 17.4763% | |
| 29.0713% | |
| 38.3338% | |
| 43.6423% | |
| 52.569% | |
| 62.34% | |
| 70.6024% | |
| 74.6666% | |
| 57.3691% | |
| 62.4179% | |
| 66.3517% | |
| 60.4775% | |
| 63.5078% | |
| 71.1034% | |
| 75.4023% | |
| 77.3964% | |
| 60.4489% | |
| 61.4592% | |
| 49.2375% | |
| 53.5077% | |
| 63.6542% | |
| 65.9645% | |
| 64.7464% | |
| 68.5918% | |
| 70.7135% | |
| 66.4528% |